CIK 1858703
Blue Owl Capital Holdings LP
Institutional 13F holdings & portfolio
Holdings
161
Portfolio Value
$1M+
Latest Report
Dec 31, 2025
Report Periods
1
Holdings
13F filings as of Dec 31, 2025 · Showing 1–50 of 161
| Ticker | Company | Shares | Value | Type |
|---|---|---|---|---|
| BLK | BLACKROCK INC COM | 946K | $1M+ | SH |
| ENGN | ENGENE HOLDINGS INC | 3.4M | $1M+ | SH |
| ENGN | ENGENE HOLDINGS INC | 3.4M | $1M+ | SH |
| NCDL | NUVEEN CHURCHILL DIRECT LEND | 2.1M | $1M+ | SH |
| NCDL | NUVEEN CHURCHILL DIRECT LEND | 2.1M | $1M+ | SH |
| OBDC | BLUE OWL CAPITAL CORPORATION | 2.0M | $1M+ | SH |
| OBDC | BLUE OWL CAPITAL CORPORATION | 2.0M | $1M+ | SH |
| LRMR | LARIMAR THERAPEUTICS INC | 6.8M | $1M+ | SH |
| LRMR | LARIMAR THERAPEUTICS INC | 6.8M | $1M+ | SH |
| CGEM | CULLINAN THERAPEUTICS INC | 2.4M | $1M+ | SH |
| CGEM | CULLINAN THERAPEUTICS INC | 2.4M | $1M+ | SH |
| CMPX | COMPASS THERAPEUTICS INC | 3.5M | $1M+ | SH |
| CMPX | COMPASS THERAPEUTICS INC | 3.5M | $1M+ | SH |
| HLLY | HOLLEY INC | 4.1M | $1M+ | SH |
| HLLY | HOLLEY INC | 4.1M | $1M+ | SH |
| CNTX | CONTEXT THERAPEUTICS INC | 7.4M | $1M+ | SH |
| CNTX | CONTEXT THERAPEUTICS INC | 7.4M | $1M+ | SH |
| CNDT | CONDUENT INC | 4.8M | $1M+ | SH |
| CNDT | CONDUENT INC | 4.8M | $1M+ | SH |
| RPTX | REPARE THERAPEUTICS INC | 3.4M | $1M+ | SH |
| RPTX | REPARE THERAPEUTICS INC | 3.4M | $1M+ | SH |
| CVEO | CIVEO CORP | 371K | $1M+ | SH |
| CVEO | CIVEO CORP | 371K | $1M+ | SH |
| SGMT | SAGIMET BIOSCIENCES INC | 1.2M | $1M+ | SH |
| SGMT | SAGIMET BIOSCIENCES INC | 1.2M | $1M+ | SH |
| EYPT | EYEPOINT INC | 393K | $1M+ | SH |
| EYPT | EYEPOINT INC | 393K | $1M+ | SH |
| DELL | DELL TECHNOLOGIES INC | 54K | $1M+ | SH |
| DELL | DELL TECHNOLOGIES INC | 54K | $1M+ | SH |
| KALV | KALVISTA PHARMACEUTICALS INC | 360K | $1M+ | SH |
| KALV | KALVISTA PHARMACEUTICALS INC | 360K | $1M+ | SH |
| MPLT | MAPLIGHT THERAPEUTICS INC | 327K | $1M+ | SH |
| MPLT | MAPLIGHT THERAPEUTICS INC | 327K | $1M+ | SH |
| ROIV | ROIVANT SCIENCES LTD | 263K | $1M+ | SH |
| ROIV | ROIVANT SCIENCES LTD | 263K | $1M+ | SH |
| IMA | IMAGENEBIO INC | 824K | $1M+ | SH |
| IMA | IMAGENEBIO INC | 824K | $1M+ | SH |
| IMMX | IMMIX BIOPHARMA INC | 986K | $1M+ | SH |
| IMMX | IMMIX BIOPHARMA INC | 986K | $1M+ | SH |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 213K | $1M+ | SH |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 213K | $1M+ | SH |
| IMRX | IMMUNEERING CORP | 665K | $1M+ | SH |
| IMRX | IMMUNEERING CORP | 665K | $1M+ | SH |
| PVLA | PALVELLA THERAPEUTICS INC NE | 40K | $1M+ | SH |
| PVLA | PALVELLA THERAPEUTICS INC NE | 40K | $1M+ | SH |
| ORIC | ORIC PHARMACEUTICALS INC | 515K | $1M+ | SH |
| ORIC | ORIC PHARMACEUTICALS INC | 515K | $1M+ | SH |
| PAYO | PAYONEER GLOBAL INC | 833K | $1M+ | SH |
| PAYO | PAYONEER GLOBAL INC | 833K | $1M+ | SH |
| PLRX | PLIANT THERAPEUTICS INC | 3.0M | $1M+ | SH |